2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
2019-08-31
SCID: 54.1/nfffnuf9
Discuss with AI
2019 ESC GuidelinesESC-EASD collaborationcardiovascular diseasesdiabetespre-diabetes
Figures from the paper
Abstract (AI)
The Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The ESC and EASD are not responsible in the event of any contradiction, discrepancy, and/or ambiguity between the Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic, or therapeutic medical strategies; however, the Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver. Nor do the Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.
Key Findings
1
Clinicians remain responsible for verifying applicable rules and regulations regarding drugs and medical devices at the time of prescription.
2
Health professionals are encouraged to fully consider these Guidelines when exercising clinical judgment and determining preventive, diagnostic, or therapeutic strategies.
3
The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases were developed in collaboration with the EASD and reflect ESC views based on available scientific and medical evidence at publication time.
4
The ESC and EASD disclaim responsibility for contradictions between these Guidelines and other official public health recommendations; clinicians must also consider updated public health authority guidance.
5
The Guidelines do not override individual clinicians' responsibility to make patient-specific decisions in consultation with patients and caregivers.
Research Object
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases (developed with the EASD)
Research Subject
Recommendations and guidance for prevention, diagnosis, and management (therapeutic and healthcare strategies) of patients with diabetes, pre-diabetes, and cardiovascular diseases based on available scientific and medical evidence
Publication Details
Publication Date
2019-08-31
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest